Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02526889n
Noun Concept
EL
No term available
EN
Pasireotide, sold under the brand name Signifor, is an orphan drug approved in the United States and the European Union for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. Wikipedia
Relations
Sources
IS A
χημική ένωση
φάρμακο
MEDICAL CONDITION TREATED
EN
pituitary-dependent Cushing's disease
SUBJECT HAS ROLE
ορμόνη

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License